跳转至内容
Merck
CN
  • Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.

Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.

Cancer genetics (2014-12-03)
Eugen C Minca, Raymond R Tubbs, Bryce P Portier, Zhen Wang, Christopher Lanigan, Mary E Aronow, Pierre L Triozzi, Arun Singh, James R Cook, Yogen Saunthararajah, Thomas P Plesec, Lynn Schoenfield, Victoria Cawich, Scott Sulpizio, Roger A Schultz
摘要

Cytogenetic alterations are strong outcome prognosticators in uveal melanoma (UVM). Monosomy 3 (-3) and MYC amplification at 8q24 are commonly tested by fluorescence in situ hybridization (FISH). Alternatively, microarray analysis provides whole genome data, detecting partial chromosome loss, loss of heterozygosity (LOH), or abnormalities unrepresented by FISH probes. Nonfixed frozen tissue is conventionally used for microarray analysis but may not always be available. We assessed the feasibility of genomic microarray analysis for high resolution interrogation of UVM using formalin-fixed paraffin-embedded tissue (FFPET) as an alternative to frozen tissue (FZT). Enucleations from 44 patients (clinical trial NCT00952939) yielded sufficient DNA from FFPET (n = 34) and/or frozen tissue (n = 41) for comparative genomic hybridization and select single nucleotide polymorphism analysis (CGH/SNP) on Roche-NimbleGen OncoChip arrays. CEP3 FISH analysis was performed on matched cytology ThinPrep material. CGH/SNP analysis was successful in 30 of 34 FFPET and 41 of 41 FZT samples. Of 27 paired FFPET/FZT samples, 26 (96.3%) were concordant for at least four of six major recurrent abnormalities (-3, +8q, -1p, +6p, -6q, -8p), and 25 of 27 (92.6%) were concordant for -3. Results of CGH/SNP were concordant with the CEP3 FISH results in 27 of 30 (90%) FFPET and 38 of 41 (92.6%) FZT cases; partial -3q was detected in two CEP3 FISH-negative cases and whole chromosome 3, 4, and 6 SNP-LOH in one case. CGH detection of -3, +8q, -8p on FFPET and FZT showed significant correlation with the clinical outcome measures (metastasis development, time to progression, survival). Results of the UVM genotyping by CGH/SNP on FFPET are highly concordant with those of the FZT analysis and with those of the CEP3 FISH analysis, and therefore CGH/SNP is a practical method for UVM prognostication. Genome-wide coverage provides additional data with potential relevance to UVM biology, diagnosis, and prognosis.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
苯酚 溶液, BioReagent, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, Molecular Biology
Sigma-Aldrich
苯酚, puriss., meets analytical specification of Ph. Eur., BP, USP, ≥99.5% (GC), crystalline (detached)
Sigma-Aldrich
苯酚 溶液, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, BioReagent, Molecular Biology
Sigma-Aldrich
苯酚, ≥99%
Sigma-Aldrich
液状苯酚, ≥89.0%
Sigma-Aldrich
苯酚, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Supelco
苯酚, Pharmaceutical Secondary Standard; Certified Reference Material
USP
苯酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
苯酚, Molecular Biology
Sigma-Aldrich
苯酚, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
苯酚, ACS reagent, ≥99.0%
Supelco
苯酚 溶液, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
苯酚, unstabilized, ReagentPlus®, ≥99%
Sigma-Aldrich
苯酚, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)
Supelco
苯酚 溶液, 5000 μg/mL in methanol, certified reference material
Sigma-Aldrich
苯酚, unstabilized, purified by redistillation, ≥99%
Sigma-Aldrich
苯酚, BioUltra, Molecular Biology, TE-saturated, ~73% (T)
Sigma-Aldrich
苯酚, natural, 97%, FG
Supelco
苯酚, PESTANAL®, analytical standard
Sigma-Aldrich
苯酚, ≥96.0% (calc. on dry substance, T)
Sigma-Aldrich
苯酚, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
苯酚 溶液, 100 μg/mL in acetonitrile, PESTANAL®, analytical standard